Getting My cannabis rescheduling To Work
The ACCENT trial (Attaining Cannabis Cessation: Analyzing N-Acetylcysteine Therapy), which started enrollment in 2014 and is particularly now in Stage 3 under the purview of UCLA, which examined using N-Acetylcysteine as a possible tool for cannabis cessation in adult individuals. Its content is presently going through evaluation and it is unpublis